567 related articles for article (PubMed ID: 9663234)
1. Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni.
Ohtsuka K; Nakamura Y; Hashimoto M; Tagawa Y; Takahashi M; Saito K; Yuki N
Ophthalmology; 1998 Jul; 105(7):1281-5. PubMed ID: 9663234
[TBL] [Abstract][Full Text] [Related]
2. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome.
Jacobs BC; Endtz H; van der Meché FG; Hazenberg MP; Achtereekte HA; van Doorn PA
Ann Neurol; 1995 Feb; 37(2):260-4. PubMed ID: 7531419
[TBL] [Abstract][Full Text] [Related]
3. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
[TBL] [Abstract][Full Text] [Related]
4. [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis].
Hayashi Y; Koga M; Takahashi M; Uchida A; Yuki N
Rinsho Shinkeigaku; 2001 Nov; 41(11):801-4. PubMed ID: 12080613
[TBL] [Abstract][Full Text] [Related]
5. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.
Koga M; Gilbert M; Li J; Koike S; Takahashi M; Furukawa K; Hirata K; Yuki N
Neurology; 2005 May; 64(9):1605-11. PubMed ID: 15883324
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan.
Takahashi M; Koga M; Yokoyama K; Yuki N
J Clin Microbiol; 2005 Jan; 43(1):335-9. PubMed ID: 15634991
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
[TBL] [Abstract][Full Text] [Related]
8. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome.
Yuki N; Takahashi M; Tagawa Y; Kashiwase K; Tadokoro K; Saito K
Ann Neurol; 1997 Jul; 42(1):28-33. PubMed ID: 9225682
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
Yuki N
Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
[TBL] [Abstract][Full Text] [Related]
10. [Guillain-barré syndrome associated Campylobacter jejuni serotype Penner 2: a case report].
Watanabe M; Kinoshita I; Hujimoto M; Nakane S; Motomura M; Nakamura T; Kusunoki S; Takahashi M; Saitoh K
No To Shinkei; 2001 Aug; 53(8):759-62. PubMed ID: 11577419
[TBL] [Abstract][Full Text] [Related]
11. Anti-ganglioside antibody and neuropathy: review of our research.
Yuki N
J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
[TBL] [Abstract][Full Text] [Related]
12. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
13. Anti-GQ1b-negative Miller Fisher syndrome after Campylobacter jejuni enteritis.
Lee KY
Pediatr Neurol; 2012 Sep; 47(3):213-5. PubMed ID: 22883289
[TBL] [Abstract][Full Text] [Related]
14. Relationship between pathogenesis of Guillain-Barre syndrome and Penner's serotypes of Campylobacter jejuni.
Li H; Yuan J; Shen B; Sun X; Hao H
Chin Med J (Engl); 1999 Sep; 112(9):794-6. PubMed ID: 11717947
[TBL] [Abstract][Full Text] [Related]
15. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
Prendergast MM; Moran AP
J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
[TBL] [Abstract][Full Text] [Related]
17. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
18. [Axonal Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni (PEN 43) enteritis].
Ihara Y; Saito K; Yoshimoto S; Hayabara T; Yuki N
Rinsho Shinkeigaku; 1995 Aug; 35(8):901-3. PubMed ID: 8665735
[TBL] [Abstract][Full Text] [Related]
19. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
